PP-C8, a potent and selective PROTAC CDK12-Cyclin K degrader, efficiently induces degradation of CDK12 and Cyclin K, with DC50 values of 416 nM and 412 nM, respectively. This compound exhibits significant synergistic antiproliferative effects when combined with a PARP inhibitor in triple-negative breast cancer (TNBC) [1].
Molecular Weight:
866.94
Formula:
C43H51FN12O7
Target:
PROTACs|||CDK
* VAT and and shipping costs not included. Errors and price changes excepted
